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Abstract 
Purpose: Young premenopausal women are susceptible to amenorrhea, which contributes 
to negative vascular remodeling and endothelial dysfunction. It is unknown whether these 
vascular changes are permanent or reversable with the restoration of estrogen levels and the 
regaining of a consistent menstrual cycle.  
Methods: This study examined subclinical cardiovascular disease risk factors and the 
vascular function of 10 eumenorrheic women, and 6 previously amenorrhoeic women. 
Anthropometric measurements, radial pulse wave analysis, carotid-femoral pulse wave velocity, 
carotid intima media thickness, beta stiffness, bone mineral density, brachial flow mediated 
dilation, and handgrip exercise blood flow measurements were taken and analyzed.  
Results: Previously amenorrhoeic women had significantly (p<0.05) lower systolic blood 
pressure, mean arterial pressure, aortic systolic blood pressure, aortic diastolic blood pressure, 
and aortic mean arterial pressure, and a higher amount of physical activity during the week than 
eumenorrheic women. There were no differences between groups in average flow velocity, 
forearm blood flow, brachial diameter, and forearm vascular conductance for flow mediated 
dilation and dynamic handgrip exercise.  
Conclusion: There were no significant vascular structure remodeling differences between 
groups, and the amenorrhoeic group displayed lower peripheral and central blood pressure, thus 
suggesting that there are no long term detrimental cardiovascular effects of previous amenorrhea.  
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1. Introduction 
Cardiovascular disease (CVD) is the leading cause of death in America for both men and 
women, however, it manifests 7 to 10 years later in women compared to men. This is thought to 
be due to the hormone estrogen, which has been shown to be beneficial in maintaining healthy 
levels of blood pressure and arterial function. Therefore, between the ages of 20 and 50, males 
are more susceptible to developing cardiovascular disease but following the menopause 
transition, females develop a significantly higher risk. When a woman goes through menopause 
her body stops producing high levels of estrogen, leaving her vessels susceptible to endothelial 
dysfunction, like plaque buildup or a decrease in the elastin to collagen ratio, resulting in 
elevated risk of cardiovascular disease, as well as depleting her bone mineral density, increasing 
risk of osteopenia or osteoporosis (Taddei et al., 1996).        
In a female’s life, it is common to miss a menstrual cycle unrelated to purposeful birth 
control methods. There are a wide range of reasons why this might be: low body fat percentage, 
an eating disorder, excessive exercise, stress, and abnormal hormone regulation.  When a 
woman’s body does not experience a menstrual cycle for several months, called amenorrhea, her 
body is not producing adequate estrogen. Because of the known link between estrogen and 
cardiovascular health, it is possible this long-term reduction of estrogen may be detrimental on 
the heart and blood vessels.  
 Research has shown females who experience amenorrhea due to estrogen deficiency are 
at a higher risk of developing low bone mineral density (osteoporosis) and premature 
cardiovascular disease (Rothman & Wierman, 2013). Using brachial flow mediated dilation, a 
2 
 
measure of endothelial function, scientists demonstrated a significant reduction in arterial 
dilation in women with amenorrhea, which is a risk factor to CVD. This research could be vital 
in determining early onset of cardiovascular disease risk factors and future overall health for 
women.  
Problem Statement 
This study determined whether women between the ages of 18-30, who previously experienced 
amenorrhea for at least six months, demonstrated impaired vascular function at the time of the 
study despite regaining a regular menstrual cycle. 
Hypothesis  
Women who have previously suffered from amenorrhea will exhibit lower endothelial function, 
stiffer vessels, and higher pressures compared to women without a history of amenorrhea. 
Summary  
Two groups of women between the ages of 18-30 were recruited. The amenorrheic group will 
consist of women who have previously been without their menstrual cycle for at least six 
consecutive months, not due to factors such as birth control, medication usage, thyroid disease, 
pregnancy, lactation, or menopause. The eumenorrheic group will be women who have 
consistently had a menstrual cycle (have not missed one for more than three consecutive 
months). Flow mediated dilation will be utilized to determine endothelial function and carotid 
beta stiffness and central (aortic) pulse wave velocity will be used to measure the stiffness of the 
vessels. The results from both groups will be compared to determine if there is impaired vascular 
function due to amenorrhea.  
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2. Literature Review   
Importance of Estrogen   
 Estrogen is the main female reproductive hormone that is primarily produced in the 
ovaries, but can also be produced by adipose tissue and the adrenal glands. Estrogen is crucial 
during the pre-pubertal stage of female secondary sex characteristics, like widening of the hips 
and development of breast tissue, pubic hair, and armpit hair (Tanner & Whitehouse, 1976).  
Once a young woman has started her menarche, estrogen is essential in regulating the growth of 
the uterine lining and regularity of menstruation (Tanner & Whitehouse, 1976; Treloar, Boynton, 
Behn, & Brown, 1967).  
 The 3 types of hormones that fall under the estrogen family are estrone (E1), estradiol 
(E2) and estriol (E3). E1 is not a very strong form of estrogen and is mostly found in small 
amounts in adipose tissue and muscle. E2 is a steroid that is produced by the ovaries and is the 
most dominant form of estrogen that can be found in both men and women. E3 is a waste 
product created after the body uses E2 and is only found in the body at significant amounts 
during pregnancy (Miller & Duckles, 2008). 
 Estrogen is crucial not only to the reproductive system, but also other organs such as the 
brain, skin, bones, heart and liver. Estrogen helps maintain body temperature and regulates parts 
of the brain for sexual development as well as chemicals like endorphins, oxytocin, serotonin, 
and dopamine. When estrogen production begins, the collagen content in the skin increases 
improving the thickness and quality of the skin. Estrogen helps preserve bone strength and 
prevent mineral loss and lowers risk of osteopenia and osteoporosis. The hormone also regulates 
cholesterol production in the liver and is a vasodilator for our vascular system (White, 2002). 
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 The average age for an adolescent girl to have her menarche is between the ages of 12-
14. A menstrual cycle every 28 to 30 days is termed eumenorrhea, or a healthy cycle. If a 
woman’s cycle occurs with intervals of greater than 35 days, then her menstruation would be 
classified as oligomenorrhea. Primary amenorrhea is defined as the absence of menarche by age 
15 and secondary amenorrhea is the cessation of menses for 3 consecutive cycles after onset of 
menarche (Anne Z Hoch et al., 2011). Secondary amenorrhea can be caused by medication, low 
body fat, stress, female athlete triad, disordered eating, deficiency in estrogen levels, and low 
levels of follicular stimulating hormone (Rothman & Wierman, 2013).   
Estrogen and Cardiovascular System  
 Estrogen aids the cardiovascular system in vasodilation, to allow more nutrients 
(proteins, carbohydrates, fats, vitamins, minerals, hormones, and H2O) to be circulated without 
high pressures (Kelley & Bendich, 1996).  The endothelium is a single cell inner most layer that 
is in direct contact with the blood and circulating nutrients. The endothelium plays a critical role 
in vascular homeostasis by regulating vessel tone, diameter, coagulation factors, vascular 
inflammation, platelet and leukocytes, and cell proliferation (Shechter et al., 2009).  
The binding of estrogen to estrogen receptors α and β, stimulate the endothelium to 
vasodilate via synthesis of nitic oxide (NO) regulating peripheral blood flow. Estrogen receptors 
(ERs) are located in all of our cells, involving many different mechanisms of action. There are 
different pathways and mechanisms of action for the interaction of estrogen and ERs. The 
Genomic pathway aids in vasodilation of the vessels through embedded ERs in the endothelial 
cell membrane (Ueda & Karas, 2013). When estrogen is in contact with theses ERs, this initiates 
gene regulation of Endothelial Nitric Oxide Synthase (eNOS), enhancing NO synthesis (Li et al., 
2007; Miller & Duckles, 2008; Stirone, Boroujerdi, Duckles, & Krause, 2005; Williams, Adams, 
5 
 
Herrington, & Clarkson, 1992). Once NO is released, it then diffuses into the smooth muscle 
cell. In the smooth muscle cell, NO interacts with GTP releasing GMP initiating relaxation of the 
smooth muscle and vasodilation(Ueda & Karas, 2013). This encourages elasticity, homeostasis 
of the vessel wall, prevention of vascular inflammation, coagulation, cell proliferation, and 
increasing vessel diameter, reducing pressures allowing the blood to circulate without turbulence 
or low sheer stress (Tousoulis, Kampoli, Tentolouris, Papageorgiou, & Stefanadis, 2012).  
Estrogen receptors are vital to the cardiovascular health of an individual. A mutation in 
ERα can cause early onset of atherosclerosis in the coronary arteries and endothelial dysfunction 
(Miller & Duckles, 2008). Estrogen and ERα has also been linked to promoting angiogenesis, 
preventing injury along the endothelial lining, and initiating the cascade of NO for vasodilation 
(Chakrabarti, Morton, & Davidge, 2014).  ERα has also been linked to positively influencing the 
calmodulin network in the endothelium, that encourages proper vasodilators factors (Tran et al., 
2016).  Estrogen and ERs are vital to the cardiovascular system because they upregulate eNOS, 
increasing the synthesis NO, encouraging vasodilation of the vessels (Chakrabarti et al., 2014; 
Chen et al., 1999).  
Estrogen Loss and Cardiovascular Dysfunction  
Statistically, women have a longer life expectancy than the average male (Taddei et al., 
1996). There are many factors that affect this such as environment, culture, genetics, and 
physiology. Women are at a significantly lower risk of developing cardiovascular disease during 
their childbearing years compared to men of similar age (Taddei et al., 1996; White, 2002). 
When a woman begins  the menopause transition, estrogen stores begin to deplete, resulting in  
vascular dysfunction (Chakrabarti et al., 2014; Mendelsohn & Karas, 1999). After a woman goes 
through menopause, their susceptibility to cardiovascular disease surpasses men (Gavin, Seals, 
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Silver, & Moreau, 2009). Over time, vascular dysfunction leads to stiffer arteries, higher blood 
pressures and progression of plaque buildup. Atherosclerosis is one of the leading causes of 
death in western society, and estrogen has been recognized to inhibit its progression (T. J. 
Anderson et al., 1995; Mendelsohn & Karas, 1999; Taddei et al., 1996). Several studies have 
provided evidence that show estrogen decreases levels of low-density lipoproteins and 
triglycerides, and increases high-density lipoproteins by affecting the expression of hepatic 
apoprotein genes (Mendelsohn & Karas, 1999). Estrogen possesses anti-atherogenic 
characteristics, but the molecular mechanism of this response is still unknown (Grosman-Rimon 
et al., 2019). 
In 2009, researchers sought to determine whether the expression of ERα is influenced by 
the amount of estrogen in the body and how that relates to endothelial function. Premenopausal 
women were tested during their early follicular phase (EF) and late follicular (LF) stage of their 
menstrual cycle and compared the values to postmenopausal women. Researchers found that the 
EF (low estrogen) stage of the menstrual cycle experienced equivalent values to postmenopausal 
women in vascular tone, which was significantly lower than the LF phase (high estrogen), which 
demonstrated higher ERα expression. ERα abundance is positively associated with eNOS 
expression to promote vasodilation of vessels (Gavin et al., 2009). With the depletion of 
estrogen, ERα and other estrogen receptors are not able to efficiently interact with the endothelial 
lining and prevent injury (Chakrabarti et al., 2014). Over time, areas of the endothelium begin to 
deteriorate, leaving it very susceptible to unstable plaque build-up eventually leading to 
atherosclerosis and coronary artery disease (T. J. Anderson et al., 1995).  
Multiple studies have been done analyzing previous amenorrhea in female athletes and its 
association with endothelial dysfunction.  Researchers found that amenorrheic athletes 
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experience significant reduction in dilation diameter of their vessels and well as loss of bone 
mineral density (Anne Z Hoch et al., 2011; Rickenlund, Eriksson, Schenck-Gustafsson, & 
Hirschberg, 2005; Zeni Hoch et al., 2003). Endothelial dysfunction is recognized to be a major 
risk factor in the development of atherosclerosis, hypertension, and heart failure (Shechter et al., 
2009). Important measurements to access the onset of CVD is central and peripheral blood 
pressures.  Blood pressure values are used to examine the pressure load experienced by the heart 
with each contraction. Central blood pressure reflects the pressure vital organs such as the heart, 
brain, and kidneys are exposed to (Sharman & Laurent, 2013). BP can be a major clinical 
implication for risk of CVD, ventricular hypertrophy, and other diseases (Sharman & Laurent, 
2013). There is a positive association between systolic and diastolic BP and risk of CVD (Sesso 
et al., 2000). Studies have shown that individuals with CVD have had a higher central BP than 
peripheral BP, compared to healthy individuals (Sharman & Laurent, 2013). This is important to 
look at when accessing endothelial dysfunction, and arterial stiffness in amenorrheic females.  
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3. Methods 
Study Design 
Sixteen subjects ranging in age from 18-30 years were recruited from the community and 
university. Ten had not experienced amenorrhea and six subjects had experienced amenorrhea 
(had not had a menstrual cycle for at least 6 months at some point in their life). Exclusion criteria 
included history of cardiovascular disease, metabolic disease, cancer, chromosomal disorder, 
pituitary tumor, current pregnancy, and anomalies of the reproductive system. Subjects on 
medications known to interfere with blood flow, blood pressure, vasodilation, or cardiovascular 
function were excluded. There was a lot of interest in this study, unfortunately some had to be 
turned away due to being currently amenorrheic.  All subjects reported to the lab for one visit, 
which consisted of signing an informed consent, filling out a health history questionnaire, and 
completing assessments of anthropometric measures including a dual-energy X-ray 
absorptiometry (DEXA) scan. Following these measures, the participant rested supine in a 
temperature controlled, darkened room for the cardiovascular measurements, which consisted of 
central and peripheral blood pressures, pulse-wave analysis and velocity, flow mediated dilation, 
carotid beta-stiffness and carotid intima-media thickness.  
 
Figure 1. Methodolgy 
 
Sequence of events and measurements that occured during a visit  
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Anthropometric Measurements 
Height was measured in centimeters using a stadiometer and weight was assessed using a 
digital scale (Healthometer 349KLX Medical Scale) in kilograms. Participants underwent a 
DEXA scan (GE Lunar iDXA; GE Healthcare, Madison, Wisconsin,USA) for assessment of 
body composition, including body fat percentage (BF%) and whole-body bone mineral density 
(BMD).  
Brachial artery blood pressure (BP) assessment 
Resting systolic BP and diastolic BP was measured at the brachial artery using an 
automated oscillometric cuff (HEM-907 XL; Omron, Shimane, Japan). BP was taken in 
duplicate and if the two values were not within 5 mmHg, additional measurements were taken 
until 2 values within 5 mmHg of each other were obtained. These averaged values were used for 
analysis.  
Pulse-Wave Velocity (PWV)  
Applanation tonomtetry (AtCor Medical, SphygmoCor Technology, Sydney, Australia) 
was used to measure pulse wave velocity (PWV). A single high-fidelity pressure transducer was 
used to measure pressure waveforms at the right common carotid artery while a blood pressure 
cuff simultaneously measured pressure waveforms at the right femoral artery (central stiffness). 
The distance between the measurement sites was measured with a tape measure in cm. The PWV 
is the difference between measurement sites and time delay between the proximal and distal 
wave forms. This calculation determines the velocity at which the blood is traveling from the 
heart to the femoral artery and is indicative of the stiffness of the central vasculature (aortic 
stiffness). A higher PWV indicates greater stiffness within the vasculature.  
 
10 
 
Central Blood Pressure  
Radial artery pressure waveforms were obtained using applanation tonometry (Millar 
Instruments, Houston, TX) and calibrated with the brachial BP obtained previously. Using a 
generalized validated transfer function(D. J. Holland, J. W. Sacre, S. J. McFarlane, J. S. 
Coombes, & J. E. Sharman, 2008; Thijssen et al., 2011), a central aortic pressure waveform is 
reconstructed from the radial artery pressure waveform (SphygmoCor; AtCor Medical, Sydney, 
Australia) to obtain central BP. Aortic mean arterial pressure and aortic pulse pressure was 
determined from the integration of the reconstructed aortic pressure waveform using the 
SphygmoCor software. This technique has been validated for use in obtaining central pressure 
(David J Holland, Julian W Sacre, Sarah J McFarlane, Jeffrey S Coombes, & James E Sharman, 
2008).  
Carotid Intima-Media Thickness 
The right common carotid artery was imaged with ultrasound (Arietta 70, Aloka, Tokyo, 
Japan) using a 7.5 MHz linear-array probe (SSD-5500; Aloka, Tokyo, Japan) 20 mm proximal to 
the carotid bifurcation. The intima–media thickness of the common carotid artery, defined as the 
distance between the leading edge of the lumen–intima interface to the leading edge of the 
media–adventitia interface of the far wall of the carotid artery, was measured at end of diastole.  
Carotid Artery Stiffness 
Using the same ultrasound and linear-array probe, the carotid artery was imaged again to 
determine the β-stiffness index (β), which adjusts arterial compliance for changes in distending 
pressure. Carotid β-stiffness was calculated as a means of adjusting arterial compliance for 
changes in distending pressure using the equation: 
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𝐶𝑎𝑟𝑜𝑡𝑖𝑑 β − stiffness 
𝑙𝑜𝑔 𝑃1/𝑃0
(𝐷1 − 𝐷0/𝐷0)
 
 
 
where P1 and P0 are the highest (systolic) and lowest (diastolic) carotid pressures and D1 and D0 
are the maximum (systolic) and minimum (diastolic) diameters. 
 
Flow Mediated Vasodilation (FMD) 
Flow-mediated vasodilation (FMD) was assessed using ultrasonography. A rapid release 
cuff was placed below the elbow joint on the widest part of the elbow. The subject laid supine 
with the right arm stabilized using an immobilizer cushion. The brachial artery was captured in 
longitudinal image sections, 5-10 cm proximal to placement of a blood-pressure cuff, using high 
frequency (5-15Mhz) linear-array probe (Thijssen et al., 2011). In B-mode, split mode used to 
simultaneously measure the arterial diameter and Doppler velocity. The flow signals were 
corrected at an insolation angle of 60 degrees.  The sample volume was placed in the middle of 
the artery, with a large sampling area. Gated images were recorded at 5 frames per second using 
Vascular Tools (Medical Imaging Applications, Coralville, IA, USA). Baseline measurements of 
resting brachial flow velocity and diameter were assessed for 60 seconds. The blood pressure 
cuff was inflated with an ischemic stimulus maintained for 5 min. Diameter and flow velocity 
was recorded 30 seconds prior to cuff release, and deflation diameter and flow velocity were 
recorded for 3 minutes post deflation. A single technician collected and analyzed all FMD data. 
These measurements are directly related to endothelial health, and can assess for possible clinical 
markers for risk of cardiovascular disease.  
Dynamic Handgrip Exercise  
Brachial blood flow was measured during dynamic hand grip exercise. In a supine 
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position, the subjects performed 3 maximal contractions, squeezing a dynamometer (TSD121C 
hand dynamometer, Biopac Systems, Inc., Goleta, CA). The best attempt of the 3 contractions 
was used as the subject’s maximal voluntary contraction (MVC). Following a 5 min rest period, 
subjects performed rhythmic handgrip exercise at 10% and 20% of MVC. Following auditory 
prompts from a metronome, the subjects contracted their dominant hand for 1 second and relaxed 
their hand for 2 seconds for a total of 5 minutes at each exercise intensity. There was a 10-minute 
rest between the 10% MVC and 20% MVC exercise bouts. Brachial artery diameter and flow 
velocity were measured using ultrasonography (Arietta 70; Aloka) with a high-frequency (7.5 
MHz) linear-array probe. Images were recorded using Vascular Tools (Medical Imaging 
Applications, Coralville, IA, USA). Resting brachial diameter and flow velocity were recorded 
for 60 seconds prior to the start of exercise. Exercise diameter and flow velocities were recorded 
and averaged during the final 60 seconds of each exercise bout (10% and 20% MVC). Average 
brachial diameter (in cm) and average brachial flow velocity (in m/s) were used to calculate 
brachial blood flow using the equation:  
𝐹𝑙𝑜𝑤 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦 𝜋 (
𝑏𝑟𝑎𝑐ℎ𝑖𝑎𝑙 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟2
4
) × 60 
Brachial blood pressures were measured at rest and during each exercise bout using an 
automated oscillometric cuff (HEM-907 XL; Omron, Shimane, Japan).  The average mean 
arterial blood pressure (in mmHg) and average brachial blood flow (mL/min) over the final 60 
seconds was used to calculate forearm vascular conductance (FVC) using the following equation: 
𝐹𝑉𝐶 =
𝑏𝑟𝑎𝑐ℎ𝑖𝑎𝑙 𝑏𝑙𝑜𝑜𝑑 𝑓𝑙𝑜𝑤
𝑚𝑒𝑎𝑛 𝑎𝑟𝑡𝑒𝑟𝑖𝑎𝑙 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒
 × 100 
Statistical Analysis  
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Data were analyzed using the SPSS software (version 20.0, SPSS, Inc., Chicago, IL). A one way 
Anova was run comparing the eumenorrhea and amenorrheic group with all of the other 
variables. A repeated measures ANOVA was used to compare the eumenorrheic and previously 
amenorrheic women  with the three different hand grip exercise intensities (Rest, MVC_10%, 
MVC_20%). When significance was detected between groups, a Bonferroni Post Hoc Analysis 
was performed. An ANCOVA was performed to control for variance and confounding factor that 
may affect significance.    
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4. Results:  
Participant characteristics are provided in Table 1. There were no statistically significant 
differences between groups in age, body mass index, bone mineral density, or body fat 
percentage. Amenorrhoeic women performed more weekly physical activity, an average of 280 
mins/wk versus the eumenorrheic group at 156 mins/wk. There were no significant differences 
between menarche age in the eumenorrheic and amenorrhoeic women. Of the 16 participants, 6 
were taking birth control (2 in the eumenorrheic group and 4 in the amenorrhoeic group). The 
women who previously experienced amenorrhea had a loss of menses between 9 to 15 months.  
PWV, IMT, beta stiffness, and endothelial function measures are presented in Table 2. 
There were no significant differences in any of these measurements between eumenorrheic and 
amenorrheic women  
Refer to Tables 3 & 4 and Figure 2. There were significant differences between groups in 
brachial systolic blood pressure, brachial mean arterial pressure, aortic systolic pressure, aortic 
diastolic pressure, and aortic mean arterial pressure. There were no significant differences 
between the eumenorrheic and amenorrhoeic group for FBF, average flow velocity, systolic and 
diastolic BPs, mean arterial pressure, and FVC during dynamic handgrip exercise. There was a 
significant difference in FBF and FVC between the three different intensities (Rest, MVC_10, 
and MVC_20).  
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Table 1. Descriptive characteristics and menstrual history  
Descriptive     
 Eumenorrheic (n=10) Amenorrheic (n=6) ANOVA p-value F Value  
Age  23 ± 2.98 22 ± 1.37 0.78 0.08 
Height (cm) 166.45 ± 5.48 166.17 ± 5.59  0.92 0.1 
Weight (kg) 61.87 ± 9 62.81 ± 6.24 0.83 0.5 
BMI 22.26 ± 2.55 22.77 ± 2.38 0.70 0.16 
BF% 28.74 ± 4.29 27.81 ± 2.80 0.65 0.21 
PA (min)* 156 ± 71.21 280 ± 30.332 0.001 16.07 
Age of 
Menarche  12.1 ± 1.4  12.7 ± 1.4  0.44 0.64 
MVC  14.8 ± 1.6  14.5 ± 2.9 0.84 0.4 
BMD  1.16  ± 0.08 1.17  ±  0.08 0.87       0.03 
Data are presented as mean ± standard deviation. *p<0.05. BMI, body mass index; BF%, body fat 
percentage; PA, Physical activity; MVC, maximum voluntary contraction; BMD, bone mineral density  
 
Table 2. Endothelial Function  
 Eumenorrheic (n=10) Amenorrheic (n=6) ANOVA p-value  F -value  
IMT 0.49 ± 0.047 0.49 ± 0.036 0.86 0.03 
Bstiff 4.19 ± 0.97 4.48 ± 0.68 0.53 0.41 
FBF 84.3 ± 27.8 69.87 ± 21.2 0.30 1.18 
MaxBD (mm) 3.52 ± 0.4 3.77 ± 0.2 0.20 2.1 
FMD% 10.9 ± 4.4 15.3 ± 5.9 0.10 2.9 
HR 60 ± 6 52 ± 9 0.07 3.8 
Brachial Diameter 3.17 ± 0.27 3.27 ± 0.24 0.50 0.6 
Avg. Flow  17.6 ± 4.3  13.5 2.6  0.06 4.2 
PWV (m/s) 17.6 ± 4.3 13.5 ± 2.6 0.18 1.9 
Data are presented as mean ± standard deviation.  
IMT, carotid intima media thickness; Bstiff, carotid beta stiffness; FBF, forearm blood flow; MaxBD, 
maximum brachial diameter; FMD%, flow mediated dilation percentage; HR, heart rate; Avg. Flow, 
average flow velocity; PWV, pulse wave velocity.  
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Table 3. Blood pressures  
Pressures Eumenorrhea Amenorrhea ANOVA p-value F-value 
SBP* 116.1 ± 6.8 106.1 ± 10.3 0.03 5.49 
DPB 66.3 ± 6.4 60.0 ± 7.2 0.09 3.32 
MAP* 82.9 ± 5.2 75.4 ± 6.4 0.02 6.57 
PP 49.8 ± 8.2 46.2 ± 11.4 0.47 0.54 
aorSBP* 100 ± 6.7 89 ± 5.9 0.005 10.9 
aorDBP* 67.2 ± 6.5 59.1 ± 5.9 0.03 6.1 
aorMAP* 82.3 ± 5.8 72.5 ± 3.5 0.002 13.7 
aorPP 32.8 ± 7.3 29.8 ± 6.3 0.40 0.7 
Data are presented as mean ± standard deviation.  
*p<0.05.  
MAP= Mean arterial pressure; *PP= Pulse pressure;  SBP: Systolic blood pressure; DBP: Diastolic blood 
pressure;  aorSBP= Aortic systolic blood pressure;  aorDBP= Aortic diastolic blood pressure; aorMAP= 
Aortic mean arterial  pressure; aorPP= Aortic Pulse Pressure  
 
Table 4. Adjusted means after controlling for physical activity  
Values:  Eumenorrhea Amenorrhea p-value 
aorDBP 65.9 ± 2.4 61.5 ± 3.4 0.344 
aorSBP* 100.4 ± 2.5 88.4 ± 3.5 0.033 
aorMAP* 81.9 ± 2 73.2 ± 2.8 0.050 
SBP 117.4 ± 3 104 ± 4.5  0.055 
MAP 82.4 ± 2.2 76.2 ± 3.1 0.188 
 
Data presented  
*p<0.05  
aorDBP= Aortic diastolic pressure; aorSBP= Aortic systolic blood pressure; aorMAP= Aortic mean 
arterial pressure; SBP= Systolic blood pressure; MAP= Mean arterial pressure
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Figure 2. Group differences in brachial diameter and flow responses to dynamic handgrip 
exercise with rest. 
A.              B.  
   
C.            D.  
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E.        F.  
    
G. 
 
Figure 1. MVC_10= Max voluntary contraction at 10%; MVC_20= Max voluntary contraction at 20%; 
FBF_SBP= forearm blood flow systolic blood pressure; FBF_DBP= forearm blood flow diastolic blood pressure; 
FBF_MAP= forearm blood flow mean arterial pressure  
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5. Discussion:  
This study assessed systemic vascular function and subclinical markers for cardiovascular 
disease in eumenorrheic and previously amenorrhoeic women. There were no significant 
differences between groups in IMT, beta stiffness, FMD average flow velocity, and pulse wave 
velocity. Amenorrhoeic women displayed lower SBP, MAP, aorSBP, aorMAP, and aorDBP. 
Collectively, these findings suggest that despite a significant period of amenorrhea, females do 
not display long-lasting negative remodeling of their vasculature after regaining a regular 
menstrual cycle. Thus, while amenorrhea and hypoestrogenic milieu is associated with 
endothelial dysfunction, this appears to be reversible assuming a menstrual cycle is regained.   
4.1 Endothelial Function  
From previous literature, researchers have found that athletes that were currently amenorrhoeic 
at the time of testing had significantly lower brachial FMD, compared to eumenorrheic athletes 
(Todd J Anderson et al., 2011; Augustine et al., 2016). Our findings demonstrated no difference 
in FMD when comparing women who previously had amenorrhea with consistently eumenorrheic 
women. The peak flow velocity is a measurement of reactive hyperemia after 5 mins of occlusion 
of the brachial artery. This measurement assesses microvascular reactivity and is associated with 
future CVD risk (Todd J Anderson et al., 2011; Lee, Martin, Fung, & Anderson, 2012). The data 
shows there is no difference between groups, indicating that the women who previously 
experienced amenorrhea did not show impaired vascular reactivity in the resistance vessels 
(Adkisson et al., 2010). Increases in vascular diameter due to shear stress is largely indicative of 
nitric oxide in a healthy endothelial single cell layer of the vessel wall (Augustine et al., 2016; 
Bank, Shammas, Mullen, & Chuang, 1998; ANNE ZENI HOCH et al., 2003). Because there were 
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no differences observed in FMD%, this suggests that endothelial dysfunction does not persist 
and/or can be reversable in young women who regain a menstrual cycle following amenorrhea.  
4.2 Arterial Stiffness  
Research shows that chronic endothelial dysfunction may lead to changes in vascular 
structure, increasing the risk of  CVD (Mitchell et al., 2005). Examples are damage or plaque 
build-up in the vessel wall or an increase in the collagen/elastin ratio. These are all important 
factors increasing risk of cardiovascular disease (Ben-Shlomo et al., 2014; van Sloten et al., 
2014). According to our data there was no difference between groups in carotid intima-media 
thickness or beta stiffness, which is consistent with previous research demonstrating that with 
proper estrogen levels and a menstrual cycle continuously maintained for 2 years, reversal of 
negative remodeling of the vasculature and endothelial function can occur (Grosman-Rimon et 
al., 2019).  
4.3 Dynamic Hand Grip Exercise  
Blood vessels dilate in response to physiological stimulus or changes like acute and chronic 
shear stress when exercising. Vessel dilation due to shear stress is endothelial dependent and is the 
result of an increase in nitric oxide release from the endothelial cells (Anton et al., 2006; Ben-
Shlomo et al., 2014). There were no significant differences detected between the groups in brachial 
diameter, average flow velocity, FBF, exercising systolic blood pressure, exercising diastolic 
blood pressure, and FVC. However, there was significance between intensities for FBF, and FVC 
(Barbosa et al., 2018). This is expected with an increase in intensity, creating more work on the 
working muscle. This increases fuel demand and encourages vasodilation to increase blood 
profusion. Since there was an increase in FBF and FVC, this suggests low vascular resistance and 
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efficient dilation mechanisms of the endothelial layer. This further encourages the theory that an 
increase in estrogen, and the regaining of a regular menstrual cycle compounded with regular 
exercise, can mitigate any negative vascular remodeling in young, healthy, and active women.   
4.4 Central and Peripheral Blood Pressures & Exercise 
Central blood pressure reflects the pressure vital organs such as the heart, brain, and kidneys 
are exposed to (Sharman & Laurent, 2013). Studies have developed a strong rationale that 
cardiovascular events are closely related to central BP (McEniery, Cockcroft, Roman, Franklin, & 
Wilkinson, 2014). This study found the previously amenorrhoeic group displayed lower central 
BP and peripheral BP when compared to the eumenorrheic group. Previous studies looking at 
amenorrheic and eumenorrheic women, have not found differences in central and peripheral BPs 
(De Souza & Williams, 2004; ANNE ZENI HOCH et al., 2003). There is an inverse relationship 
between exercise and blood pressure. It is known that endurance exercise has a positive effect on 
the cardiovascular system by reducing blood pressure (Shephard & Balady, 1999). During 
exercise, there is an increase in shear stress on the vessel wall, initiating vasodilation that persists 
into the post-exercise period, resulting in post exercise hypotension and an overall  lower blood 
pressure set point (Swain et al., 2003). Estrogen is also thought to help increase the bioavailability 
of nitric oxide also resulting in vasodilation, and when compounded with exercise is thought to 
encourage angiogenesis and the regulation of blood flow and pressures (Swain et al., 2003). 
According to our data, there were differences between groups in physical activity, with the 
previously amenorrhoeic group exercising more than the eumenorrheic group. Because the 
amenorrhoeic group displayed lower central and peripheral blood pressures, the significantly 
higher physical activity level may be the reason for the discrepancy. We followed up with a one-
way ANCOVA to determine the effect of physical activity on BP and we were able to determine 
22 
 
that PA in minutes per week did not impact the significant difference between groups in aortic 
SBP (p=0.03) and aortic MAP (p=0.05), but did eliminate significance seen in aorSBP, brachial 
SBP and brachial MAP, although brachial SBP was trending (p=0.055) (adjusted means reported 
in Table 3).  Since blood pressures that were significant are not longer with physical activity being 
controlled for. This suggests that physical activity may have a substantial effect on the 
cardiovascular health of young women, even despite the previous presence of amenorrhea. It is 
unknown why the aorSBP and aorMAP were significant once physical activity was controlled for, 
since this was an unexpected find, it would be beneficial to look at how many years the participants 
had exercises, to see if this had any effect on these values.  
4.6 Limitations 
Since there is a significant difference in physical activity between the two groups, it would 
have been ideal to match physical activity levels between groups. Future research should assess 
groups with similar activity levels in order to appropriately elucidate the role of previous 
amenorrhea on vascular function.   
 We also did not directly measure estrogen or confirm ovulation status, therefore it is 
plausible that some participants may have experienced early ovulatory bleeding or breakthrough 
that can sometimes occur, impacting vascular measures and estradiol concentrations (Augustine et 
al., 2016). In addition, women taking oral contraceptives were not excluded from this study. 
However, all participants were tested during their early follicular stage of their menstrual cycle, or 
during the placebo pill phase, in order to control for hormonal levels during testing.   
 Another limitation to consider is that the vascular health of the previously amenorrheic 
women was unknown while they did not experience a menstrual cycle. While unlikely, it is 
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possible there was not any negative vascular remodeling, causing no significant difference to be 
found.  
4.7 Future Studies   
It would be beneficial in the future to organize a longitudinal study, that follows women 
who are currently amenorrhea, and perform similar measurements as this study. Once the 
participants have regained a consistent menstrual cycle, it would be beneficial to perform the same 
measurements and compare the results to a eumenorrheic group matched for physical activity.  
Another parameter that needs to be looked at is women who are/were amenorrheic and not 
physically active. Since our study found results suggesting the benefits of physical activity despite 
menstrual status, it would be beneficial to look at the effects of amenorrhea on women who are 
not physically active and see if there are long term effects on cardiovascular health.   
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5. Conclusion 
In this study we found that there were no significant differences in endothelial function 
between previously amenorrhoeic and eumenorrheic women. In addition, groups displayed no 
differences in aortic or carotid arterial stiffness. Significance was observed in the minutes of 
physical activity per week, as well as SBP, MAP, aorSBP, aorDBP, and aorMAP. This research 
highlights that previous amenorrhea experienced early in life, may not have long-term negative 
cardiovascular repercussions as long as regular menstruation resumes.  
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